Tier 4 — mechanistic

Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin

Maher P

Genes & Nutrition 2009 4(4):297-307

Bibliography

DOI: 10.1007/s12263-009-0142-5
PubMed: PMID 19756810
PubMed Central: PMC2775892
Funding: Supported by the Michael J. Fox Foundation and the Alzheimer's Association.
Competing interests: Not stated in the reviewed sections.

Study snapshot

Design	Narrative review summarising evidence that fisetin maintains neuronal function during ageing via multiple mechanisms: antioxidant activity and glutathione maintenance, mitochondrial ATP preservation, anti-inflammatory (microglial and 5-lipoxygenase) activity, proteasome activity enhancement, and cognitive enhancement (CREB phosphorylation, long-term potentiation, object recognition and Morris water maze performance in young and aged mice).
Model	Not applicable — review; cites HT22 nerve cells, rat primary cortical neurons, rat hippocampal slices, and young/aged mouse behavioural models from the author's and others' primary studies.
Sample	Not applicable.
Intervention	Not applicable — review of fisetin's neuroprotective and cognition-enhancing mechanisms across cited primary studies (oral doses of 5-500 mg/kg food referenced from cited mouse studies).
Duration	Not applicable.
Endpoints	Not applicable — narrative synthesis of endpoints reported across cited primary studies (glutathione levels, ATP levels, Nrf2/HO-1 induction, 5-LOX inhibition, proteasome activity, CREB phosphorylation, long-term potentiation, object recognition index, Morris water maze escape latency).

What the study showed, in plain terms

Brain function declines with age through several independent mechanisms — oxidative stress, mitochondrial dysfunction, inflammation, protein-clearance decline, and reduced neurotrophic signalling — and this review by a Salk Institute researcher argues that fisetin is unusual in touching all of them.

The review walks through fisetin's antioxidant and glutathione-boosting effects, its ability to preserve mitochondrial ATP under oxidative stress, its anti-inflammatory action on microglia and 5-lipoxygenase, its modest enhancement of proteasome activity, and its cognitive benefits — including enhanced long-term potentiation and memory in both young and aged mice fed fisetin.

Bottom line: this is the author's own synthesis of a multi-year research programme (not new data in this specific paper), making the case that fisetin's value lies in hitting many small, complementary targets rather than one dominant mechanism — a reasonable rationale for a nutraceutical, but the review predates fisetin's now-prominent senolytic/senotherapeutic literature, which emerged after 2009.

Key findings

The review synthesises evidence that fisetin maintains ageing brain function through several parallel mechanisms: increasing intracellular glutathione and Nrf2 signalling, preserving mitochondrial ATP under oxidative stress, inhibiting 5-lipoxygenase and microglial activation, modestly enhancing proteasome activity, and improving long-term memory in both young and aged mice (via ERK-dependent CREB phosphorylation and hippocampal long-term potentiation), with oral fisetin exhibiting high blood-brain-barrier penetration potential in an in vitro MDR-MDCK model.

What this study can and cannot tell us

This is a single-author narrative review, not new primary data; its conclusions depend on the quality of the underlying cited studies, most of which are rodent or cell-culture work rather than human trials. Published in 2009, it predates fisetin's later senolytic/senotherapeutic research programme and should not be treated as a current synthesis of the field.